Weight Loss Medical weight loss programs featuring GLP-1 medications, including compounded Semaglutide and Tirzepatide (where appropriate), as well as FDA-approved brand medications such as Wegovy, Ozempic, Zepbound, and Mounjaro when clinically appropriate and available
Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system
"Hair growth (and loss) are quite dependent on factors such as diet, essential vitamins, bodily stress and genetics." "This study references that those who lost more than 20% of their body weight had higher rates of hair loss than those who didnt," Davis noted
Emipshere's SNAC carrier achieves provisional GRAS status for use with nutrients added to foods and dietary supplements
Prevention of renal decline now involves a multi-target approach combining hormonal blockade with metabolic protection
Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, et al